Pavmed (NSDQ:PAVM) subsidiary Lucid Diagnostics announced that Lucid publicly filed a registration statement related to a proposed initial public offering (IPO). The number of shares of common stock and the price range for the offering have not yet been determined, according to a news release. Lucid Diagnostics intends to list its common stock on the Nasdaq market […]
Otolaryngology/Ear, Nose & Throat (ENT)
Lyra Therapeutics appoints new CFO
Lyra Therapeutics (NSDQ:LYRA) announced today that it appointed Jason Cavalier as its new chief financial officer, effective today. Cavalier succeeds the company’s current CFO, Don Elsey, who is retiring while he remains expected to serve in an advisory role to assist with the transition. Get the full story at our sister site, Drug Delivery Business News.
Lyra touts non-human trial of XTreo drug-eluting implant
Lyra Therapeutics (NSDQ:LYRA) is touting preclinical data for its XTreo drug-eluting implant for dosing in local sinus tissues. Watertown, Massachusetts-based Lyra’s preclinical results were published — “Drug Release and Pharmacokinetic Evaluation of Novel Implantable Mometasone Furoate Matrices in Rabbit Maxillary Sinuses” — were published online in the peer-review journal, American Journal of Rhinology & Allergy. Get the […]
Impel NeuroPharma prices $45M offering following FDA approval for migraine treatment
Impel NeuroPharma (NSDQ:IMPL) announced that it priced an underwritten public offering of common stock worth $45 million. The offering includes 3 million shares of common stock priced to the public at $15 per share, with gross proceeds set to total $45 million before deducting underwriting discounts and commissions and other offering expenses payable by Impel NeuroPharma. […]
AFYX touts trial of biodegradable drug delivery patch
AFYX Therapeutics today touted results from a study exploring the delivery of antibody fragments using the company’s Rivelin technology. The preclinical study, conducted in collaboration with the University of Sheffield in the United Kingdom, evaluated Rivelin for delivering the antibody fragments directly to inflamed tissue in mucosal diseases. Get the full story at our sister site, […]
FDA approves Impel NeuroPharma’s nasal spray for treating migraines
Impel NeuroPharma (NSDQ:IMPL) announced today that the FDA approved its Trudhesa nasal spray for treating migraine in adults. Seattle-based Impel NeuroPharma plans to launch Trudhesa commercially early next month. The company’s shares took a massive hit, though, dropping -19.3% at $18.65 per share by market close and continuing to slide down -0.8% at $18.50 after hours […]
Aerin Medical touts study of chronic rhinitis treatment tech
Aerin Medical today touted one-year results from a trial evaluating the safety and efficacy of its RhinAer system in those with chronic rhinitis. Sunnyvale, Calif.–based Aerin designed RhinAer as a temperature-controlled radiofrequency technology used to disrupt nerve signals that cause chronic rhinitis symptoms. According to a news release, the study demonstrated that, following a single […]
FDA clears Boston Scientific’s Exalt Model B single-use bronchoscope
Boston Scientific (NYSE:BSX) announced today that it received FDA 510(k) clearance for its Exalt Model B single-use bronchoscope. Marlborough, Mass.-based Boston Scientific designed the Exalt Model B for use in bedside procedures within the intensive care unit and operating room, according to a news release. Uses for the device include a wide range of bronchoscopy […]
Aerin Medical touts study of nasal airway obstruction treatment
Aerin Medical today touted results from a three-month study of its VivAer treatment for nasal airway obstruction (NAO). Sunnyvale, Calif.-based Aerin’s VivAer was studied in the VATRAC trial, with results published by the International Forum of Allergy and Rhinology. According to a news release, the study confirmed the safety and efficacy of VivAer in treating […]
FDA approves Oticon Medical’s Neuro cochlear implant system
Oticon Medical today said the FDA has granted premarket approval for the company’s Neuro Cochlear Implant System. Somerset, N.J.-based Oticon Medical designed the Neuro system to treat people 18 years or older with bilateral severe-to-profound sensorineural hearing loss and who have limited benefits from fitted hearing aids. “At Oticon Medical, we are passionate about using […]
Preceptis Medical launches tympanostomy tube system for in-office pediatric ear tube procedures
Preceptis Medical today said it has launched its Hummingbird tympanostomy tube system for office-based pediatric ear tube procedures. The Maple Grove, Minn.–based company designed the device with an ergonomic design to allow for more efficient ear tube delivery in children. Get the full story on our sister site, Medical Tubing + Extrusion.
